Is 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene? Is 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene safe for nursing mother and child? Does 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene extracts into breast milk? Does 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene has any long term or short term side effects on infants? Can 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene influence milk supply or can 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene decrease milk supply in lactating mothers?
2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene lactation summary
- DrLact safety Score for 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene usage in lactation
We are working on a comment for this product.
Answer by DrLact: About 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene usage in lactation
2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene is not approved for marketing in the United States by the U.S. Food and Drug Administration, but is available in other countries. Limited information indicates that maternal oral doses of up to 4 mg daily or depot injections of 40 mg every 2 weeks produce low levels in milk and breastfed infants' serum, and cause no adverse developmental consequences. Until more data are available, 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene should be used with careful monitoring during breastfeeding.
2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene Side Effects in Breastfeeding
A woman took 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene 1 mg and nortriptyline 100 mg daily during pregnancy and 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene 4 mg and nortriptyline 125 mg daily immediately postpartum. She exclusively breastfed her infant. Over a 4-month period, the infant showed no signs of adverse drug effects and had normal motor development with a maternal dosage of 2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene 2 mg daily and nortriptyline 75 mg daily.[2]
2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene Possible Effects in Breastfeeding
2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene can increase serum prolactin[3][4][5] and has caused galactorrrhea.[6] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs
Mesoridazine(Unsafe)
Droperidol(Low Risk)
Loxapine(Unsafe)
Paliperidone(Safe)
Haloperidol(Safe)
Sulpiride(Safe)
Fluphenazine(Low Risk)
Clozapine(Low Risk)
Chlorpromazine(Low Risk)
Ziprasidone(Unsafe)
Aripiprazole(Low Risk)
Trifluoperazine(Safe)
Thiothixene(Unsafe)
Thioridazine(Unsafe)
Flupenthixol(Safe)
Risperidone(Safe)
Quetiapine(Safe)
Zuclopenthixol(Safe)
Pimozide(Unsafe)
Perphenazine(Safe)
Olanzapine(Safe)
Asenapine(Low Risk)
Droperidol(Low Risk)
Sulpiride(Safe)
Domperidone(Safe)
Metoclopramide(Safe)
Flupenthixol(Safe)
Zuclopenthixol(Safe)